Literature DB >> 16554270

The provision and funding of contraceptive services at publicly funded family planning agencies: 1995-2003.

Laura Duberstein Lindberg1, Jennifer J Frost, Caroline Sten, Cynthia Dailard.   

Abstract

CONTEXT: Publicly funded family planning agencies face significant challenges in delivering quality services to low-income women because of the higher costs of newer contraceptive methods, changes in health care financing and a growing uninsured population.
METHODS: In 2003, 627 of a nationally representative sample of 956 U.S. agencies receiving public funding for family planning services responded to an eight-page survey. Responses were compared with results from similar surveys in 1995 and 1999 to describe changes in the availability of contraceptive methods, policies on method provision and funding issues. Variation was examined by agency type and Title X funding status.
RESULTS: Between 1995 and 2003, the number of contraceptive methods available to women increased and agencies reduced barriers to oral and emergency contraceptives by liberalizing policies for their provision. By 2003, many agencies offered the newest contraceptive methods available-the progestin-only IUD (58%), the patch (76%) and the vaginal ring (39%). However, more than half of agencies did not stock certain methods because of their cost, and some key funding sources had declined. Between 1995 and 2003, the proportion of agencies receiving Medicaid funding fell from 91% to 80%, and the proportion of clients paying full fee for their contraceptive services fell from 19% to 14%. The share of agencies waiving fees for adolescents fell from 66% in 1999 to 44% in 2003.
CONCLUSIONS: Continued funding challenges limit the ability of publicly funded providers to offer all available methods to all women.

Entities:  

Mesh:

Year:  2006        PMID: 16554270     DOI: 10.1363/psrh.38.037.06

Source DB:  PubMed          Journal:  Perspect Sex Reprod Health        ISSN: 1538-6341


  9 in total

1.  Condoms for dual protection: patterns of use with highly effective contraceptive methods.

Authors:  Karen Pazol; Michael R Kramer; Carol J Hogue
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

2.  Extending Medicaid coverage for family planning services: Alabama's first four years.

Authors:  Janet M Bronstein; Annie Vosel; Shery K Georsel; Charlena Freeman; Leigh Anne Payne
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

3.  Trends and determinants of reproductive health service use among young women in the USA.

Authors:  J Potter; J Trussell; C Moreau
Journal:  Hum Reprod       Date:  2009-09-20       Impact factor: 6.918

4.  Accessibility of family planning services: impact of structural and organizational factors.

Authors:  Lorraine V Klerman; Kay A Johnson; Chiang-Hua Chang; Phyllis Wright-Slaughter; David C Goodman
Journal:  Matern Child Health J       Date:  2006-11-28

5.  Trends in US women's use of sexual and reproductive health care services, 1995-2002.

Authors:  Jennifer J Frost
Journal:  Am J Public Health       Date:  2008-08-13       Impact factor: 9.308

6.  Knowledge and attitudes about long-acting reversible contraception among Latina women who desire sterilization.

Authors:  Kari White; Kristine Hopkins; Joseph E Potter; Daniel Grossman
Journal:  Womens Health Issues       Date:  2013 Jul-Aug

7.  Factors associated with condom use among male college students in Wuhan, China.

Authors:  Lu Long; Ting Yuan; Min Wang; Chuan Xu; Jieyun Yin; Chengliang Xiong; Sheng Wei; Shaofa Nie
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

8.  Patterns of contraceptive use among Mexican-origin women.

Authors:  Kari L White; Joseph E Potter
Journal:  Demogr Res       Date:  2013

9.  Association between college health services and contraceptive use among female students at five colleges in Wuhan, China: a cross-sectional study.

Authors:  Lu Long; Zhenhua Chen; Yun Shi; Sheng Wei; Shaofa Nie; Yi Liu
Journal:  BMC Public Health       Date:  2016-09-05       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.